A novel method of generating prostate cancer metastases from orthotopic implantsCOREY, Eva; QUINN, Janna E; VESSELLA, Robert L et al.The Prostate. 2003, Vol 56, Num 2, pp 110-114, issn 0270-4137, 5 p.Article

Microsatellite instability and mismatch repair target gene mutations in cell lines and xenografts of prostate cancerXIAODONG SUN; CESHI CHEN; VESSELLA, Robert L et al.The Prostate. 2006, Vol 66, Num 6, pp 660-666, issn 0270-4137, 7 p.Article

Placental bone morphogenetic protein (PLAB) gene expression in normal, pre-malignant and malignant human prostate: Relation to tumor development and progressionTHOMAS, Regi; TRUE, Lawrence D; LANGE, Paul H et al.International journal of cancer. 2001, Vol 93, Num 1, pp 47-52, issn 0020-7136Article

Protease-Activated Receptor-I is Upregulated in Reactive Stroma of Primary Prostate Cancer and Bone MetastasisXIAOTUN ZHANG; WENBIN WANG; TRUE, Lawrence D et al.The Prostate. 2009, Vol 69, Num 7, pp 727-736, issn 0270-4137, 10 p.Article

Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patientsSCHMITTGEN, Thomas D; TESKE, Sabine; VESSELLA, Robert L et al.International journal of cancer. 2003, Vol 107, Num 2, pp 323-329, issn 0020-7136, 7 p.Article

KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancerCESHI CHEN; BHALALA, Hina V; VESSELLA, Robert L et al.The Prostate. 2003, Vol 55, Num 2, pp 81-88, issn 0270-4137, 8 p.Article

Prostate cancer expression of runt-domain transcription factor Runx2, a key regulator of osteoblast differentiation and functionBRUBAKER, Kristen D; VESSELLA, Robert L; BROWN, Lisha G et al.The Prostate. 2003, Vol 56, Num 1, pp 13-22, issn 0270-4137, 10 p.Article

Identification of prostate specific membrane antigen (PSMA) as the target of monoclonal antibody 107-1A4 by ProteinChip®; Array, surface-enhanced laser desorption/ionization (SELDI) technologyWANG, Shunyou; DIAMOND, Deborah L; MICHAEL HASS, G et al.International journal of cancer. 2001, Vol 92, Num 6, pp 871-876, issn 0020-7136Article

Genetic aberrations in prostate cancer by microarray analysisSARAMÄKI, Outi R; PORKKA, Kati P; VESSELLA, Robert L et al.International journal of cancer. 2006, Vol 119, Num 6, pp 1322-1329, issn 0020-7136, 8 p.Article

EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-IndependentKEXIN XU; ZHENHUA JEREMY WU; HAN XU et al.Science (Washington, D.C.). 2012, Vol 338, Num 6113, pp 1465-1469, issn 0036-8075, 5 p.Article

Comparative Analyses of Chromosome Alterations in Soft-Tissue Metastases within and across Patients with Castration-Resistant Prostate CancerHOLCOMB, Ilona N; YOUNG, Janet M; NELSON, Peter S et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 19, pp 7793-7802, issn 0008-5472, 10 p.Article

RAD001 (Everolimus) Inhibits Growth of Prostate Cancer in the Bone and the Inhibitory Effects Are Increased by Combination With Docetaxel and Zoledronic AcidMORGAN, Todd M; PITTS, Tiffany E. M; GROSS, Ted S et al.The Prostate. 2008, Vol 68, Num 8, pp 861-871, issn 0270-4137, 11 p.Article

The Current State of Preclinical Prostate Cancer Animal ModelsPIENTA, Kenneth J; ABATE-SHEN, Cory; SIMONS, Jonathon W et al.The Prostate. 2008, Vol 68, Num 6, pp 629-639, issn 0270-4137, 11 p.Article

Telomerase activity in disseminated prostate cancer cellsPFITZENMAIER, Jesco; ELLIS, William J; ARFMAN, Edward W et al.BJU international (Papier). 2006, Vol 97, Num 6, pp 1309-1313, issn 1464-4096, 5 p.Article

Expression of androgen receptor coregulators in prostate cancerLINJA, Marika J; PORKKA, Kati P; KANG, Zhikang et al.Clinical cancer research. 2004, Vol 10, Num 3, pp 1032-1040, issn 1078-0432, 9 p.Article

LuCaP 35: A new model of prostate cancer progression to androgen independenceCOREY, Eva; QUINN, Janna E; BUHLER, Kent R et al.The Prostate. 2003, Vol 55, Num 4, pp 239-246, issn 0270-4137, 8 p.Article

Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodesSHARIAT, Shahrokh F; ROUDIER, Martine P; WILCOX, George E et al.Cancer research (Baltimore). 2003, Vol 63, Num 15, pp 4662-4670, issn 0008-5472, 9 p.Article

Hsp90 Inhibitor 17-AAG Inhibits Progression of LuCaP35 Xenograft ProstateTumors to Castration ResistanceO'MALLEY, Katherine J; LANGMANN, Gabrielle; AI, Junkui et al.The Prostate. 2012, Vol 72, Num 10, pp 1117-1123, issn 0270-4137, 7 p.Article

Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice VariantsMOSTAGHEL, Elahe A; MARCK, Brett T; PLYMATE, Stephen R et al.Clinical cancer research (Print). 2011, Vol 17, Num 18, pp 5913-5925, issn 1078-0432, 13 p.Article

SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancerDONG, Xue-Yuan; RODRIGUEZ, Carmen; STEVENS, Victoria L et al.Human molecular genetics (Print). 2008, Vol 17, Num 7, pp 1031-1042, issn 0964-6906, 12 p.Article

The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: A comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancerPFITZENMAIER, Jesco; ELLIS, William J; HAWLEY, Sarah et al.Urologic oncology. 2007, Vol 25, Num 3, pp 214-220, issn 1078-1439, 7 p.Article

Targeting factors involved in bone remodeling as treatment strategies in prostate cancer bone metastasisVESSELLA, Robert L; COREY, Eva.Clinical cancer research. 2006, Vol 12, Num 20, issn 1078-0432, 6285s-6290s, 2Conference Paper

Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancerXIAODONG SUN; FRIERSON, Henry F; MIURA, Yutaka et al.Nature genetics. 2005, Vol 37, Num 4, pp 407-412, issn 1061-4036, 6 p.Article

Metastases of prostate cancer express estrogen receptor-betaLAI, Janice S; BROWN, Lisha G; TRUE, Lawrence D et al.Urology (Ridgewood, NJ). 2004, Vol 64, Num 4, pp 814-820, issn 0090-4295, 7 p.Article

Hyperbaric oxygen does not accelerate latent in vivo prostate cancer: implications for the treatment of radiation-induced haemorrhagic cystitisKIAN TAI CHONG; HAMPSON, Neil B; BOSTWICK, David G et al.BJU international (Papier). 2004, Vol 94, Num 9, pp 1275-1278, issn 1464-4096, 4 p.Article